SML Genetree
PrivateLast Round
Series A
Nov 11, 2021
Total Funding Raised
$8.4M
Company Overview
SML Genetree operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series A round in November 2021.
SML Genetree is a biotechnology company that develops and manufactures multiplex molecular diagnostic technologies and clinical diagnostic kits for infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SML Genetree Comparables
Compare SML Genetree with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Seasun Biomaterials | 85% | |
| SolGent Co., Ltd. | 82% | |
| Wizbiosolutions Inc. | 81% |
For institutional investors. Book with your work email.
SML Genetree Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
SML Genetree Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Widwin Investment | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors grew 55% MoM, reaching 2.5K.
- Jan 23, 2026
Monthly visitors grew 156% MoM, reaching 2.7K.
For institutional investors. Book with your work email.
SML Genetree Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SML Genetree's valuation, stock price, and market status.
Is SML Genetree a public or private company?
SML Genetree is a private company.
What is the current stock price of SML Genetree?
SML Genetree is a private company, so its shares have no public market price. Caplight tracks SML Genetree's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SML Genetree worth (valuation)?
Valuation information for SML Genetree is not publicly available.
Can I buy SML Genetree stock?
SML Genetree shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SML Genetree's last funding round?
SML Genetree's most recent funding round was Series A on November 11, 2021.
Who are the main investors in SML Genetree?
Key investors in SML Genetree include Widwin Investment.
Will SML Genetree IPO soon?
No public IPO plans have been announced for SML Genetree.
How can I track SML Genetree secondary market activity?
Caplight tracks bids, offers, and trades in SML Genetree's shares on secondary markets.